3-Bromopyridine-4-Boronic Acid: Enabling Smarter Chemistry

Reliable Tools for Innovative Synthesis

Every time I've worked with heterocyclic boronic acids in medicinal chemistry or advanced materials labs, I learned quickly how selective the choice really is. Not every building block offers the same edge, especially if you need clean Suzuki-Miyaura coupling. 3-Bromopyridine-4-boronic acid steps up as one of those rare reagents that brings both a functional bromine atom and a versatile boronic acid group onto the pyridine ring. Unlike many similar molecules, it's flexible enough to help both in fragment elaboration and late-stage modification. Many new pharmaceutical compounds begin as such customizable fragments, and this is one reason interest in 3-bromopyridine-4-boronic acid remains high among both industry researchers and academic chemists.

Specifications and Model Information

This product usually goes by the name 3-bromopyridine-4-boronic acid, with the model number 262357-39-1, which matches its CAS registry. In the dry, solid state, it appears as a pale crystalline powder. During storage and transport, a tightly sealed container and cool, dry conditions help guard its quality. The molecular formula is C5H5BBrNO2 and formula weight is about 201.82 g/mol. I have never seen a well-stocked chemistry research storeroom without a careful checklist for purity; for this compound, you typically want a purity above 97% for best results. Most reputable vendors offer detailed certificates of analysis and spectral data, allowing research teams to cross-check batch quality, and that transparency keeps trust high between suppliers and users.

What Makes This Compound Useful?

Any chemist who’s tried to build complex nitrogen-containing scaffolds will notice the advantage with this molecule right away. The bromine atom at the third position on the pyridine ring means you can run halogen-lithium exchange, or other directed couplings, choosing when and where to activate it. The boronic acid at the fourth position comes with known reactivity in Suzuki coupling, one of the most widely used reactions to link aromatic rings together in drug development. Instead of struggling to protect and deprotect or swap out substituents after coupling, 3-bromopyridine-4-boronic acid hands you both tools at once. That’s a huge boost for time and resource savings in multi-step syntheses.

Not every heterocyclic compound holds up in real-world workflows as well as this one. Some similar molecules can hydrolyze too quickly, or their boronic acid group becomes inactive if the ambient moisture climbs. With standard precautions, I’ve found this molecule’s stability and shelf life both meet practical research needs.

How It Stands Apart From Similar Boronic Acids

People sometimes ask whether boronic acid reagents truly differ much from one another. In early-stage methods development, it might not matter. Later on, though, once you’re scaling up to several tens of grams, differences in solubility and reactivity become obvious. Compared to the closely related 2-bromopyridine boronic acid or even pyridylboronic acids with different halogen positions, the 3-bromo-4-boronic acid form offers a better balance of reactivity and selectivity during coupling and substitution. When you need cross-coupling with minimal side-products and precise control over product outcome, this particular structure makes life a lot easier.

In the biotech sector, rapid iteration is the name of the game. I've seen chemists push for more molecular diversity in lead optimization, and reagents like this allow access to frameworks that would otherwise require lengthy synthetic routes. If you compare it to 3-chloro or 3-iodopyridine boronic acids, the bromine gives a more manageable leaving group than chlorine in cross-coupling, but it’s less costly and more stable than iodine. Purification steps end up tighter and product isolation is simpler.

Role in Medicinal Chemistry and Material Science

Medicinal chemists face a balancing act—they want to explore new chemical space but without sacrificing project speed. The pyridine ring serves as a privileged structure in pharmaceutical design because of its tuning effects on potency, solubility, and metabolism. 3-Bromopyridine-4-boronic acid makes it possible to stitch together varied molecules, such as kinase inhibitors or CNS-active drugs, with greater precision. I recall a project focused on anti-viral small molecules; our team used this compound in late-stage diversification, allowing us to present a batch of analogs with minimal synthetic overhead. That flexibility meant fewer disappointing dead-ends and more time probing real biological effects.

In addition, materials chemists interested in organic electronics or ligands for special metal complexes also reach for this reagent. Boronic acids bridge carbon frameworks to larger architectures, so they’re key in crafting polymers with electronic or optical properties. With a bromine and boronic acid in one molecule, the doors open to new ligand backbones and functional chain ends.

Streamlining Synthetic Routes

Keeping synthesis efficient isn’t just about the number of steps. Each intermediate gets tracked for cost, toxicity, and environmental footprint. Traditional routes to biaryl or heterocyclic scaffolds used to rely on multiple halogenation, protection, and deprotection steps. Having 3-bromopyridine-4-boronic acid on hand lets synthetic chemists bypass several of those steps, targeting direct coupling where possible. Pinpointed installation of the boronic acid allows flexible late-stage modifications, often giving rise to more potent analogs or fresh patent opportunities. In my experience, projects using smarter starting materials move faster toward both lab validation and publication.

Supporting Facts

The Suzuki-Miyaura reaction has become a foundational method in pharma discovery and bulk chemical manufacturing; reports suggest over a quarter of currently marketed drugs passing through a stage involving Suzuki coupling. Pyridine rings, meanwhile, turn up in more than 10% of novel small molecule therapeutics. A reagent that can merge these two features has clear importance. Data from recent medicinal chemistry journals highlights how boronic acids like this one deliver higher yields and cleaner purifications compared to more troublesome or sensitive reagents.

From a risk point of view, the toxicology of pyridine boronic acids is considered manageable in a controlled-lab setting, especially compared with nitro or strongly electron-withdrawing substituents. The bromine atom, while reactive under catalyst conditions, does not create significant storage risks if standard lab safety measures are followed. Researchers are keen to abide by green chemistry principles wherever possible, and replacing less-selective or more hazardous coupling partners supports sustainability in the research pipeline.

Addressing Practical Challenges

Every practical chemist recognizes the occasional pain points: solubility bottlenecks, inconsistent reactivity, and equipment fouling. In my benchwork days, switching from less-soluble aryl halides to a compound like 3-bromopyridine-4-boronic acid often brought a smoother process. Water compatibility matters in the real lab; boronic acids sometimes suffer from hydrolysis, but structural features of this molecule—including the pyridine nitrogen’s influence—seem to slow down unwanted decomposition, especially with careful pH control.

Another practical bonus: post-coupling purification. This molecule, being neither too greasy nor too polar, often behaves well on silica columns and in standard liquid-liquid extractions. I can’t count how often that saved hours or more of hands-on troubleshooting. Later steps—such as removing palladium residues or separating side-products—tend to go more quickly, reducing both bottlenecks and material waste.

Potential Solutions to User Pain Points

Although 3-bromopyridine-4-boronic acid comes with plenty of strengths, there are always further optimizations to consider. Hydrolysis can be checked through packaging improvements, such as use of moisture-barrier containers and desiccants. For researchers working in high-throughput environments, using this compound in pre-formulated tablets or sealed break-open ampoules can minimize exposure and maximize consistency. Encouraging suppliers to offer real-time batch analytics, verified by independent labs, might increase batch-to-batch trust and make troubleshooting easier for lab managers.

For labs focused on green chemistry or minimizing toxic metal use, there’s value in switching to less hazardous Suzuki-type catalysts, such as nickel or copper complexes, paired with this reagent. Minimizing handling steps and scaling guidance from suppliers can both minimize losses and cut costs. Collaborating with universities and industry partners to share reaction outcomes using 3-bromopyridine-4-boronic acid helps the wider community identify and solve ongoing issues, whether related to selectivity, recycling, or scalability.

How the Industry is Evolving

Global demand for advanced heterocyclic boronic acids keeps rising as both personalized medicine and complex electronics development accelerate. Suppliers realize that well-characterized, traceable materials pull ahead of the pack. Digital records, blockchain-backed ingredient documentation, and batch-level analytics are showing up in procurement pipelines at larger research groups. In smaller startups, self-service web portals let chemists order targeted building blocks, like 3-bromopyridine-4-boronic acid, with tailored delivery formats.

Open-access tools and reaction databanks, such as the Open Reaction Database or ChemRxiv, now list real-world reaction outcomes for pyridine derivatives. These resources give users clues about which reaction conditions best unlock the potential of functionalized boronic acids, helping prevent wasted time and money on unsuitable protocols.

Best Practices in Purchasing and Handling

I've found that working with top-tier suppliers means more than a shiny website. Checking for recent certificates of analysis, ensuring compliance with international transport standards, and demanding clear storage recommendations protect both team safety and research budgets. For this compound, even small lapses in moisture control can harm performance. A tip I picked up from an old mentor: refrigerate boronic acids in a sealed container with fresh silica gel, out of direct light, and always label open dates. Simple steps like these mean less troubleshooting and higher yield during actual runs.

Within the lab, short training sessions on the unique behaviors of boronic acid intermediates support new researchers, especially those unfamiliar with pyridine derivatives. Investing in pilot reactions, rather than jumping straight to multi-gram scales, pays off over and over. In my group, we kept a log of each reagent’s quirks, and 3-bromopyridine-4-boronic acid ended up flagged as “reliable, manageable” compared to fussier cousins.

Looking Ahead With Smarter Chemistry

The story of 3-bromopyridine-4-boronic acid isn’t just about filling a shelf or meeting procurement quotas. Research teams in pharma, materials, and specialty chemicals all build on the same insight: reliable, multifunctional reagents save time, money, and frustration, letting scientists focus on solving big problems. By selecting robust, dual-purpose building blocks, whole projects accelerate, whether that leads to a new treatment for disease, a breakthrough polymer, or a sharper sensor. I remember seeing the compound’s adoption in my peers’ projects and realizing the difference that smart reagent design makes at the lab bench.

Chemists thrive on practical outcomes. When a molecule offers the right reactivity, stability, and handling profile, it quickly moves from niche to staple. Over the years, 3-bromopyridine-4-boronic acid has proved its worth, powering discoveries both in my own work and throughout the broader research enterprise. I expect its central role to keep growing as synthetic barriers fall and new applications surface across the sciences.